Cemex SAB de CV has a consensus price target of $7.89 based on the ratings of 8 analysts. The high is $10 issued by Goldman Sachs on April 26, 2024. The low is $4.9 issued by Redburn Partners on December 8, 2022. The 3 most-recent analyst ratings were released by JP Morgan, Barclays, and JP Morgan on August 21, 2024, July 31, 2024, and July 8, 2024, respectively. With an average price target of $8.5 between JP Morgan, Barclays, and JP Morgan, there's an implied 30.77% upside for Cemex SAB de CV from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Cemex (NYSE:CX) was reported by JP Morgan on August 21, 2024. The analyst firm set a price target for $8.00 expecting CX to rise to within 12 months (a possible 23.08% upside). 9 analyst firms have reported ratings in the last year.
The latest analyst rating for Cemex (NYSE:CX) was provided by JP Morgan, and Cemex their overweight rating.
The last upgrade for Cemex SAB de CV happened on July 31, 2024 when Barclays raised their price target to $9. Barclays previously had an equal-weight for Cemex SAB de CV.
The last downgrade for Cemex SAB de CV happened on April 24, 2024 when B of A Securities changed their price target from $9 to $9 for Cemex SAB de CV.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cemex, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cemex was filed on August 21, 2024 so you should expect the next rating to be made available sometime around August 21, 2025.
While ratings are subjective and will change, the latest Cemex (CX) rating was a with a price target of $0.00 to $8.00. The current price Cemex (CX) is trading at is $6.50, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.